Literature DB >> 10928159

Detection and typing of human papillomaviruses by means of polymerase chain reaction and fragment length polymorphism in male genital lesions.

M Grce1, K Husnjak, M Skerlev, J Lipozencić, K Pavelić.   

Abstract

We investigated the distribution of genital human papillomaviruses (HPVs) among 171 consenting men of which four were involved twice in this study. The DNA was obtained from 7 normal tissues and 168 genital lesions of which 115 were diagnosed as condylomata acuminata, 17 as condylomata plana and 36 as HPV-associated lesions (papules, lichen-like lesions, etc.). The DNA samples were analysed for the presence and type of HPV DNA (HPV type 6, 11, 16, 18, 31 or 33) by means of polymerase chain reaction (PCR). Out of 175 specimens tested, 140 (80%) were HPV positive and 35 (20%) HPV negative. There were 81.43% (114 out of 140) typed HPVs, while 18.57% (26 out of 140) remained untyped. Most samples were HPV 6/11 positive (92 out of 114, 80.7%). Restriction fragment length polymorphism (RFLP) of HPV 6/11 PCR products in 89.13% (82 out of 92) and 10.87% (10 out of 92) specimens corresponded to HPV 6 and HPV 11, respectively. The frequency of other HPVs was low, i.e. there were 4.57% (8 out of 175), 1.71% (3 out of 75) and 0.57% (1 out of 175) HPV type 16, 18 and 33, respectively. There were 10 out of 175 (5.71%) cases of multiple HPV infections, of which 6 out of 10 were cases with HPV 6 and other HPV types. This raises the total prevalence of HPV type 6 to 50.29% (88 out of 175) in the study-population. The clinical diagnosis condylomata acuminata was preferentially associated with low-risk HPVs (types 6 and 11), while other lesions, especially condylomata plana, with high-risk HPVs (types 16, 18, 31 and 33) and untyped HPVs. The male population, indeed, represents a reservoir of HPV infection and directly influences cervical cancerogenesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10928159

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  6 in total

1.  Prevalent serum antibody is not a marker of immune protection against acquisition of oncogenic HPV16 in men.

Authors:  Beibei Lu; Raphael P Viscidi; Yougui Wu; Ji-Hyun Lee; Alan G Nyitray; Luisa L Villa; Eduardo Lazcano-Ponce; Roberto J Carvalho da Silva; Maria Luiza Baggio; Manuel Quiterio; Jorge Salmeron; Danelle C Smith; Martha E Abrahamsen; Mary R Papenfuss; Heather G Stockwell; Anna R Giuliano
Journal:  Cancer Res       Date:  2011-11-28       Impact factor: 12.701

Review 2.  HIV-1-Mediated Acceleration of Oncovirus-Related Non-AIDS-Defining Cancers.

Authors:  Jessica Proulx; Maria Ghaly; In-Woo Park; Kathleen Borgmann
Journal:  Biomedicines       Date:  2022-03-25

3.  Condyloma accuminatum of the male urethra: A case report.

Authors:  Abdelrazak Meliti; Abdulrahman Hawari; Haneen Al-Maghrabi; Ghadeer Mokhtar
Journal:  SAGE Open Med Case Rep       Date:  2020-02-21

Review 4.  Human Papillomaviruses-Associated Cancers: An Update of Current Knowledge.

Authors:  Ena Pešut; Anamaria Đukić; Lucija Lulić; Josipa Skelin; Ivana Šimić; Nina Milutin Gašperov; Vjekoslav Tomaić; Ivan Sabol; Magdalena Grce
Journal:  Viruses       Date:  2021-11-06       Impact factor: 5.048

Review 5.  Virus-Driven Carcinogenesis.

Authors:  Yuichiro Hatano; Takayasu Ideta; Akihiro Hirata; Kayoko Hatano; Hiroyuki Tomita; Hideshi Okada; Masahito Shimizu; Takuji Tanaka; Akira Hara
Journal:  Cancers (Basel)       Date:  2021-05-27       Impact factor: 6.639

6.  Recurrent respiratory papillomatosis: HPV genotypes and risk of high-grade laryngeal neoplasia.

Authors:  Turid Omland; Kathrine A Lie; Harriet Akre; Lars Erik Sandlie; Peter Jebsen; Leiv Sandvik; Dag Andre Nymoen; Davit Bzhalava; Joakim Dillner; Kjell Brøndbo
Journal:  PLoS One       Date:  2014-06-11       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.